Sharat Singh

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Violeta Serra, Maurizio Scaltriti, Ludmila Prudkin et al. · Oncogene · 2011 · 530 citations · Full text

An <i>In vivo</i> Platform for Translational Drug Development in Pancreatic Cancer

Belén Rubio‐Viqueira, Antonio Jimeno, George Cusatis et al. · Clinical Cancer Research · 2006 · 411 citations · Full text

mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer

Moshe Elkabets, Sadhna Vora, Dejan Juric et al. · Science Translational Medicine · 2013 · 344 citations · Full text

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

Niels Vande Casteele, Ann Gils, Sharat Singh et al. · The American Journal of Gastroenterology · 2013 · 342 citations

Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.

Edwin F. Ullman, Hrair Kirakossian, Sharat Singh et al. · Proceedings of the National Academy of Sciences · 1994 · 327 citations

Immunocytochemical Technique, Engineering, Luminescence Property +16